Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Mathew

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Replacement of Chalcone-Ethers with Chalcone-Thioethers as Potent and Highly Selective Monoamine Oxidase-B Inhibitors and Their Protein-Ligand InteractionsBijo Mathew, Jong Min Oh, Ahmed Khames, et al.
Current Computer-Aided Drug Design|August 12, 2024
3D-QSAR, Pharmacophore Modeling, ADMET and DFT Studies of Halogenated Conjugated Dienones as Potent MAO-B InhibitorsGitha Elizabeth Mathew, Chonny Herrera-Acevedo, Marcus Tullius Scotti, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 24, 2022
Biological investigation of <i>N</i>-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitorsIlaria D'Agostino, Githa Elizabeth Mathew, Paola Angelini, et al.
Plos One|October 4, 2023
SARS-CoV-2 infection in 3,241 School working staffs: Impact of SARS CoV-2 variants of concern [Wild, B.1.1.7 and Omicron]Moza Alishaq, Jameela Ali Al Ajmi, Mohammed Shaheen, et al.
Plos One|June 20, 2025
Correction: SARS-CoV-2 infection in 3,241 School working staffs: Impact of SARS CoV-2 variants of concern [Wild, B.1.1.7 and Omicron]Moza Alishaq, Jameela Ali Al Ajmi, Mohammed Shaheen, et al.
Medchemcomm|December 21, 2018
Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitorsBijo Mathew, Seung Cheol Baek, Della Grace Thomas Parambi, et al.
Global Epidemiology|July 18, 2024
SARS-CoV-2 infection prevalence, risk factors, and outcomes among non-clinical-related service providers in a national healthcare systemMoza Aishaq, Hanaa Nafady-Hego, Fatma Ben Abid, et al.
Elife|December 13, 2024
Key epigenetic and signaling factors in the formation and maintenance of the blood-brain barrierJayanarayanan Sadanandan, Sithara Thomas, Iny Elizabeth Mathew, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Replacement of Chalcone-Ethers with Chalcone-Thioethers as Potent and Highly Selective Monoamine Oxidase-B Inhibitors and Their Protein-Ligand InteractionsBijo Mathew, Jong Min Oh, Ahmed Khames, et al.
Current Computer-Aided Drug Design|August 12, 2024
3D-QSAR, Pharmacophore Modeling, ADMET and DFT Studies of Halogenated Conjugated Dienones as Potent MAO-B InhibitorsGitha Elizabeth Mathew, Chonny Herrera-Acevedo, Marcus Tullius Scotti, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 24, 2022
Biological investigation of <i>N</i>-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitorsIlaria D'Agostino, Githa Elizabeth Mathew, Paola Angelini, et al.
Plos One|October 4, 2023
SARS-CoV-2 infection in 3,241 School working staffs: Impact of SARS CoV-2 variants of concern [Wild, B.1.1.7 and Omicron]Moza Alishaq, Jameela Ali Al Ajmi, Mohammed Shaheen, et al.
Plos One|June 20, 2025
Correction: SARS-CoV-2 infection in 3,241 School working staffs: Impact of SARS CoV-2 variants of concern [Wild, B.1.1.7 and Omicron]Moza Alishaq, Jameela Ali Al Ajmi, Mohammed Shaheen, et al.
Medchemcomm|December 21, 2018
Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitorsBijo Mathew, Seung Cheol Baek, Della Grace Thomas Parambi, et al.
Global Epidemiology|July 18, 2024
SARS-CoV-2 infection prevalence, risk factors, and outcomes among non-clinical-related service providers in a national healthcare systemMoza Aishaq, Hanaa Nafady-Hego, Fatma Ben Abid, et al.
Elife|December 13, 2024
Key epigenetic and signaling factors in the formation and maintenance of the blood-brain barrierJayanarayanan Sadanandan, Sithara Thomas, Iny Elizabeth Mathew, et al.
Pageof 11